Global Implantable Remote Patient Monitoring Devices Market

Report Scope

The current report provides detailed information about the market’s implantable remote patient monitoring (IRPM) devices. It provides market projections through 2029 and market ranks for key players. The report details the market share of IRPM devices based on product, indication and end users. This market is segmented into implantable cardiovascular monitoring devices, implantable brain monitoring devices, gastrointestinal monitoring (smart pills), implantable hematological monitoring devices, implantable respiratory monitoring devices, implantable musculoskeletal monitoring devices and others based on product. Based on indication, the market is segmented into cardiovascular diseases, brain disorders, gastrointestinal diseases, diabetes, chronic respiratory diseases, musculoskeletal diseases, and others. By end user, the market is categorized into hospitals and clinics, home healthcare settings, and others. A detailed competitive landscape includes major players, market share and recent strategic developments.

Additionally, the report offers a regional analysis, breaking down market trends and growth prospects across different geographical areas. It includes market forecasts, consumer insights, and a thorough supply chain analysis, addressing distribution channels and key suppliers. By examining these elements, the report aims to provide a comprehensive view of the market’s current state and future potential, assisting stakeholders in making well-informed decisions and identifying strategic opportunities within the IRPM devices industry.

Report Includes

32 data tables and 47 additional tables

An overview of the global market for implantable remote patient monitoring (IRPM) devices

Analyses of the global market trends, with sales data for 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029

Estimates of the market size and revenue forecast for the global market, and a corresponding market share analysis by product, indication, end user, and region

Discussion of the underlying opportunities in the implantable remote patient monitoring devices market, with the integration of internet of things (IoT) and wireless technologies for the diagnosis and treatment of diseases

Assessment of factors driving the industry’s growth, current trends, market opportunities and restraints, and the technological advances that will shape the future market

Market share analysis of the major global corporations, the competitive landscape, product developments, marketing strategies and revenue forecasts

A discussion of the industry’s ESG challenges and practices

Emphasis on the increasingly stringent government regulations as well as the increasing adoption of miniaturized multi-sensing devices in chronic disease management and self-health management

Latest information on mergers and acquisitions, partnerships, agreements, collaborations, and other strategic alliances

Identification of the major stakeholders and analysis of recent developments and segmental revenues

Profiles of the leading companies, including Boston Scientific Corp., Medtronic, Abbott Laboratories, Dexcom Inc., and Biotronik

Companies Mentioned

ABBOTT
AVERTIX MEDICAL INC.
BIOTRONIK
BOSTON SCIENTIFIC CORP.
CARDIAC RMS
DEXCOM INC.
EBR SYSTEMS INC.
ENDOTRONIX INC.
INJECTSENSE INC.
IMPULSE DYNAMICS
MEDICO S.R.L.
MEDTRONIC
PROFUSA INC.
QURA LLC.
VITALCONNECT